Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 39-1554806 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To improve Cancer patient outcomes by advancing the science, development and application of Cancer immunology and Immunotherapy through our core values of interaction/integration, innovation, translation, diversity and inclusion and leadership in the field. Sitc aims to make Cancer Immunotherapy a standard of care and the word "cure" a reality for Cancer patients everywhere.
Principal Officer
James L Gulley MD PHD
Total Revenue
$12.8M
FY2024
Total Expenses
$14.1M
FY2024
Net Assets
$20.3M
Program Ratio
84.6%
expenses on programs
Employees
0
Volunteers
259
Board Members
13
Voting
13
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.